Assam : Junior doctors assault tribal govt officer; intern suspended

Assam : Government official in Cachar district was beaten up with an iron rod allegedly by a group of junior doctors at Silchar Medical College and Hospital (SMCH), a police official said on Tuesday.

The authorities suspended an intern doctor in connection with the incident. Inspector of Drugs in the Directorate of Health Services, Bonrai Rongmei, had gone to SMCH to visit his ailing sister-in-law on Monday night and had asked a junior doctor about the blood tests when he misbehaved with him. Rongmei alleged that the junior doctor asked him rudely whether he was educated enough to understand these things and even after he told them that he was a government employee, he continued to shout at him. He claimed that as the arguments continued, several doctors gathered, dragged him to a corner, slapped him and began hitting him with an iron rod. Following the incident, local people reached the hospital and started protesting against the doctors. A police team reached the hospital and brought the situation under control, Cachar Superintendent of Police Numal Mahatta said. ”We are investigating the matter and SMCH authorities are cooperating with us,” Mahatta said. SMCH Principal Dr Bhaskar Gupta and a team of doctors met District Commissioner Rohan Kumar Jha on Tuesday and also the family members of the victim. Gupta said that they have suspended an intern doctor for three months. An inquiry committee has also been instituted to investigate the matter and if any other doctors are found involved in the incident, action will be taken against them, he said. Meanwhile, All Assam Rongmei Naga Students Union condemned the incident, describing it as a hate crime and demanded immediate arrest of the accused doctors.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March